Urikal Oral Solution is a scientifically formulated solution containing Potassium Citrate and Citric Acid, designed to help manage urinary tract conditions by maintaining an optimal acid-base balance in the urine. This preparation is particularly effective in preventing the formation of kidney stones, also known as urolithiasis, and managing metabolic disorders that can lead to stone formation. By alkalinizing the urine, Urikal Oral Solution reduces the risk of stone formation and supports kidney health.

Potassium Citrate acts as an alkalizing agent, increasing urinary citrate levels and neutralizing excess acidity in the urine. Citric Acid complements this effect by enhancing citrate availability and promoting urinary pH balance. Together, these agents provide a safe and effective approach to preventing kidney stone recurrence and maintaining urinary tract health.

রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন

Indications

Urikal Oral Solution is indicated for:

• Prevention and management of urinary calculi (kidney stones), particularly uric acid and cystine stones

• Metabolic acidosis in conditions such as renal tubular acidosis

• Urinary acidification disorders where maintaining proper urinary pH is necessary

• Supporting long-term management in patients with recurrent stone formation

Therapeutic Class

Urinary alkalinizing and stone prevention agents

Pharmacology

Potassium Citrate is an alkalizing agent that works by metabolizing into bicarbonate in the body, increasing urinary citrate and pH. This creates an environment less favorable for the crystallization of uric acid, cystine, and calcium-containing stones.

Citric Acid enhances the solubility of urinary citrate and works synergistically with potassium citrate to maintain urinary pH within the target range of 6–7.5, which helps prevent stone formation.

After oral administration, potassium citrate is rapidly absorbed and metabolized, with potassium and citrate ions excreted primarily via the kidneys. This process effectively increases urinary citrate levels, inhibits calcium crystallization, and neutralizes urinary acidity. Regular use helps stabilize urine composition, preventing stone recurrence.

Dosage and Administration

• The recommended dose of Urikal Oral Solution depends on the severity of the condition and patient age.

• Typically, 5–10 ml (equivalent to 1500–3000 mg potassium citrate + 250–500 mg citric acid) 2–3 times daily is administered, preferably after meals.

• The solution should be measured using a standard measuring cup or syringe to ensure accurate dosing.

• Patients should maintain adequate hydration to support urinary flow and enhance the therapeutic effect.

• Dosage may be adjusted based on urinary pH monitoring to maintain a slightly alkaline urine.

Important: The solution should be shaken well before each use. Avoid exceeding the prescribed dose to prevent hyperkalemia or electrolyte imbalance.

রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন

Contraindications

• Severe renal impairment

• Hyperkalemia or potassium-sparing conditions

• Known hypersensitivity to potassium citrate or citric acid

Side Effects

Most patients tolerate Urikal Oral Solution well. Mild side effects may include:

• Gastrointestinal discomfort such as nausea or diarrhea

• Stomach cramps

• Rarely, hyperkalemia if overdosed

Patients should report persistent or severe side effects to their healthcare provider immediately.

Precautions and Warnings

• Monitor serum potassium levels in patients at risk of hyperkalemia

• Use with caution in patients with cardiovascular disorders

• Not recommended for children without medical supervision

• Adequate fluid intake is essential during therapy to prevent stone formation

Pregnancy and Lactation

Urikal Oral Solution should be used in pregnancy only if clearly needed and prescribed by a physician. Lactating mothers should consult a healthcare provider before use.

Storage Conditions

Store in a cool, dry place away from direct sunlight. Keep the bottle tightly closed and out of reach of children.

Drug Class

Urinary alkalinizing and stone prevention agents.